Family Legacy Inc’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-3,340
Closed -$213K 111
2019
Q4
$213K Buy
+3,340
New +$191K 0.12% 115
2019
Q1
Sell
-3,240
Closed -$168K 117
2018
Q4
$168K Hold
3,240
0.15% 106
2018
Q3
$201K Hold
3,240
0.16% 103
2018
Q2
$179K Hold
3,240
0.15% 106
2018
Q1
$205K Buy
+3,240
New +$208K 0.19% 101
2017
Q3
Sell
-4,240
Closed -$236K 49
2017
Q2
$236K Sell
4,240
-1,005
-19% -$54.7K 0.24% 89
2017
Q1
$285K Buy
+5,245
New +$288K 0.3% 80

Other funds holding BMY

Family Legacy Inc's BMY Position: Q1 2020 in Review

Family Legacy Inc sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 3,340 shares — an estimated $213K sold.

Family Legacy Inc first reported a position in BMY in Q1 2017 and held it in 7 quarters. The position peaked at $285K in Q1 2017. 2,149 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

  • Family Legacy Inc reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
  • Family Legacy Inc sold 3,340 Bristol-Myers Squibb shares in Q1 2020, an estimated $213K.
  • Family Legacy Inc first reported a position in Bristol-Myers Squibb in Q1 2017 and held it in 7 quarters.
  • Family Legacy Inc's Bristol-Myers Squibb position peaked at $285K in Q1 2017.
  • 2,149 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Family Legacy Inc's 13F filing for Q1 2020, filed 12 May 2020.